A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

PET-CT is widely recommended in international clinical guidelines, including those of the European Association of Nuclear ...

With more than three decades of experience supporting tens of thousands of clinical scans nationwide, Positron continues to position itself as a trusted partner to nuclear cardiology practices seeking ...

GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT) technology for new clinical pathways to help ...

MedGenome has announced a majority investment in Mumbai-headquartered Medcare Management Services, a radiology and nuclear medicine provider specialising in PET-CT and molecular imaging services.

MedGenome to acquire a majority stake in Medcare Management Services, expanding its western India footprint and creating a ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...